MONTREAL, March 15, 2013 /CNW Telbec/ - Following the decision by
Minister of Health and Social Services Dr. Réjean Hébert to set a
ceiling on the price of proton pump inhibitors (PPIs), medicines used
to treat a specific digestive disorder, the Gastrointestinal Society (www.badgut.org) is of the opinion that the Québec government is instead creating
stomach aches for over 200,000 patients with digestive problems who may
be faced with a medication change in the coming months.
The Gastrointestinal Society is distressed to see that the Minister of
Health and Social Services has decided to unilaterally change the
choice of 200,000 Québec patients by instituting a switch to substitute
"Not all medicines are created equal. The forced substitution of one
pharmaceutical product by another is an act that could prove dangerous
because different patients can react very differently depending on the
selected medicines. Yet, it is the Minister that will choose your
medicine for you because price is all that matters," said Gary Fabian,
Gastrointestinal Society Executive Director for Québec and Atlantic
In his decision, Minister Hébert announced that as of next October 1,
all patients with digestive disorders should use the least expensive
products on the market for a specific medical condition, regardless of
the treatment chosen by physician and patient together.
"Though the notice indicates that the government is implementing the
measure for economic reasons, namely that it will result in major
savings, it does not take into account added costs that will ensue,
including visits to the doctor, the ER, as well as additional tests and
analyses. Put simply, these promised savings do not take into account
extra costs that will occur," added Mr. Fabian.
About the Gastrointestinal Society
In 1976, the Canadian Society of Intestinal Research (CSIR) arose as the
first registered charity in Canada to enhance public awareness by
providing patient and professional information and funding medical
research on a wide array of gastrointestinal diseases and disorders.
There are as many as 6 million Canadians with irritable bowel syndrome
(IBS), more than 9 million with functional dyspepsia, there could be as
many as 8 million with chronic acid reflux (GERD), and a further
165,000 suffering from chronic inflammatory bowel disease (Crohn's and
ulcerative colitis). These are only a few examples of the conditions we
cover. Surprisingly, despite these alarming statistics, the
gastrointestinal field is critically under-funded.
SOURCE: Gastrointestinal Society
For further information:
Executive Director, Québec and Atlantic Canada